A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Test Efficacy and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Wake-up Stroke (WAKE-UP)
Götz Thomalla(Universität Hamburg), Florent Boutitie(Université Claude Bernard Lyon 1), Salvador Pedraza(Hospital Clínic de Barcelona), Bastian Cheng(Universität Hamburg), Vincent Thijs(Florey Institute of Neuroscience and Mental Health), Tae‐Hee Cho(Université Claude Bernard Lyon 1), Josep Puig(Institut d'Investigació Biomèdica de Girona), Pascal Roy(Université Claude Bernard Lyon 1), Jens Fiehler(Universität Hamburg), Leif Østergaard, Ivana Galinović(Universität Hamburg), Christian Gerloff(Universität Hamburg), Norbert Nighoghossian(Hospices Civils de Lyon), Jochen B. Fiebach(Pathodiagnostik Berlin), Martin Ebinger(Charité - Universitätsmedizin Berlin), Claus Z. Simonsen(Universität Hamburg), Matthias Endres(German Center for Neurodegenerative Diseases), Keith W. Muir(University of Glasgow)
Cited by 148
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
|New England Journal of Medicine|2019|1k
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
|New England Journal of Medicine|2018|856